You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carfilzomib

Showing 51 - 75 of 159
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

Terminated
Has Results
  • Hodgkin Disease
  • Lymphoma, Non-hodgkin
  • New York, New York
    Columbia University Irving Medical Center - Center for Lymphoid
Jun 28, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Encinitas, California
  • +5 more
Mar 15, 2022

Multiple Myeloma Trial in Chicago, Detroit, Poznan (Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Jun 29, 2021

MULTIPLE MYELOMA (MM) Trial in Rionero in Vulture (Carfilzomib, Cyclophosphamide, Lenalidomide)

Active, not recruiting
  • MULTIPLE MYELOMA (MM)
  • Carfilzomib
  • +3 more
  • Rionero in Vulture, Italy
    IRCCS--CROB --CROB di Rionero in di Rionero in Vulture
Apr 28, 2021

Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +3 more
  • Graz, Austria
  • +20 more
Jan 18, 2022

Myeloma Trial in Denmark, Norway, Sweden (Carfilzomib, Lenalidomide, PET-CT)

Recruiting
  • Myeloma
  • Carfilzomib
  • +3 more
  • Copenhagen, Denmark
  • +3 more
Sep 15, 2021

Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)

Recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

Multiple Myeloma Trial in Canada, United States (Ibrutinib, Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Duarte, California
  • +16 more
Nov 24, 2021

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +3 more
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Pomalidomide)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Birmingham, Alabama
  • +45 more
Dec 6, 2022

Plasma Cell Myeloma Trial in Worldwide (isatuximab SAR650984, carfilzomib, dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • isatuximab SAR650984
  • +2 more
  • San Francisco, California
  • +69 more
May 10, 2022

Lymphoma, Non-Hodgkin, Lymphoma Trial in Davis, San Diego, San Francisco (Carfilzomib, Bendamustine, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Carfilzomib
  • +2 more
  • Davis, California
  • +2 more
Apr 21, 2021

Multiple Myeloma Trial run by the NCI (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 10, 2021

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (CC-92480, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +130 more
Jan 27, 2023

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +11 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

CD20 Positive, Recurrent DLBCL, Refractory DLBCL Trial in Buffalo (drug, other, biological)

Active, not recruiting
Has Results
  • CD20 Positive
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 11, 2021

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Smoldering Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Daratumumab)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Carfilzomib
  • +3 more
  • Tampa, Florida
  • +9 more
Jul 8, 2022

Multiple Myeloma Trial in Spain (Carfilzomib, Dexamethasone, cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Tenerife, Islas Canarias, Spain
  • +23 more
Apr 1, 2021

Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed Multiple Myeloma
  • Belantamab mafodotin
  • +2 more
  • Badalona, Spain
  • +14 more
Sep 5, 2022

Multiple Myeloma Trial in United States (Iberdomide, Daratumumab, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Durham, North Carolina
  • +5 more
Jun 22, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Fountain Valley, California
  • +107 more
Dec 7, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Carfilzomib
  • +10 more
  • Orange, California
  • +86 more
Nov 14, 2022

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Bendamustine Hydrochloride, Carfilzomib,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bendamustine Hydrochloride
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 7, 2021